New Jersey Division of Child Protection and Permanency

133 A.3d 643, 444 N.J. Super. 325
New Jersey Superior Court Appellate Division·Decided February 25, 2016·No. A-3662-13T3·Published·Cited by 10 cases

Opinion

RECORD IMPOUNDED

NOT FOR PUBLICATION WITHOUT THE APPROVAL OF THE APPELLATE DIVISION

SUPERIOR COURT OF NEW JERSEY APPELLATE DIVISION DOCKET NO. A-3662-13T3

NEW JERSEY DIVISION OF CHILD PROTECTION AND PERMANENCY, APPROVED FOR PUBLICATION

February 25, 2016 Plaintiff-Respondent, APPELLATE DIVISION v.

K.M.,

Defendant-Appellant. ______________________________

IN THE MATTER OF G.G., a minor. ______________________________

Argued November 12, 2015 - Decided February 25, 2016

Before Judges Fuentes, Koblitz and Gilson.

On appeal from Superior Court of New Jersey, Chancery Division, Family Part, Middlesex County, Docket No. FN-12-65-14.

Clara S. Licata, Designated Counsel, argued the cause for appellant (Joseph E. Krakora, Public Defender, attorney; Ms. Licata, on the brief).

James F. LaFargue, Deputy Attorney General, argued the cause for respondent (John J. Hoffman, Acting Attorney General, attorney; Melissa Dutton Schaffer, Assistant Attorney General, of counsel; Mr. LaFargue, on the brief).

Danielle Ruiz, Designated Counsel, argued the cause for minor G.G. (Joseph E. Krakora, Public Defender, Law Guardian, attorney; Ms. Ruiz, on the brief).

The opinion of the court was delivered by

FUENTES, P.J.A.D.

Defendant K.M.1 is the biological mother of G.G., a boy born

in April 2013. She appeals from the order entered by the Family

Part finding she abused or neglected G.G. within the meaning of

N.J.S.A. 9:6-8.21(c)(4)(a), after the child was born manifesting

signs of physical distress caused by withdrawal from opioid

addiction. We affirm.

G.G. was born at St. Peter's University Hospital in New

Brunswick weighing 9 pounds and 3.6 ounces, and showing no

apparent signs of distress or abnormalities. However, during

the first three days after his birth, the medical staff noted

the infant was exhibiting symptoms consistent with opioid

withdrawal. G.G. was thereafter admitted to the neonatal

intensive care unit (NICU) for respiratory distress. The

hospital staff contacted the Division of Child Protection and

Permanency (Division), which dispatched a caseworker to meet and

discuss the situation with defendant.

1 We use initials and fictitious names to protect the confidentiality of the participants in these proceedings pursuant to Rule 1:38-3(d).

2 A-3662-13T3 Upon arriving at the hospital, the Division caseworker saw

G.G. at the NICU before meeting with defendant. The caseworker

noted G.G. was "jerking his arm up above his head." By this

time, the nursing staff was actively monitoring the infant for

withdrawal symptoms. Defendant admitted to the caseworker she

was addicted to oxycodone, sold as Roxicodone or "Roxis," prior

to her pregnancy.2 Defendant also admitted to illicitly

acquiring Suboxone,3 an opioid analog prescribed by physicians to

treat the physical symptoms of opioid withdrawal. She told the

caseworker she ingested Suboxone two to three times per week and

smoked marijuana during her pregnancy.

The NICU medical staff began treating G.G. with morphine

after learning defendant's history of opioid addiction,

including her efforts to self-medicate the symptoms of

withdrawal by using Suboxone during her pregnancy. G.G. spent a

total of twenty-two days in the hospital to recover from the

withdrawal symptoms. He was released to defendant and his

biological father in late May 2013.

2 K.M. testified the opioid-based prescription pain medication she took was not prescribed to her by a physician. She took the medication a physician prescribed for her friend to alleviate the pain the friend experienced from a knee injury. 3 Suboxone is a controlled dangerous substance within the meaning of N.J.S.A. 2C:35-2, and can be acquired legally in a pharmacy only with a prescription from a licensed physician.

3 A-3662-13T3 On July 9, 2013, the Division filed an Order to Show Cause

(OTSC) and a Verified Complaint against defendant in the Family

Part pursuant to N.J.S.A. 30:4C-12, seeking legal custody of

G.G. and responsibility for his physical welfare and

supervision. That same day the Division amended the complaint

to charge defendant with abuse or neglect of G.G. under N.J.S.A.

9:6-8.21(c)(4). The Family Part granted the Division's request

and scheduled the return date for the OTSC for August 12, 2013.

By the time the case returned to the court, defendant had

completed substance abuse counseling and had attended supervised

visitation with G.G., who was by then cleared of any medical

issues related to his opioid withdrawal. The court conducted

fact-finding hearings on December 9, 2013, January 29, 2014,

February 18, 2014, and February 24, 2014. The evidence

presented at these hearings established that defendant became

addicted to oxycodone approximately four years before she gave

birth to G.G. in 2013. She began taking her friend’s

prescription pain medication to alleviate the pain caused by a

sprained ankle she suffered while playing college sports. She

continue to ingest this medication in pill form multiple times a

week until she realized she was pregnant in October 2012.

While pregnant, defendant came to the realization that

continuing to abuse these drugs would be detrimental to the

4 A-3662-13T3 welfare of the fetus. Based on the research she conducted

online, K.M. discovered that abruptly stopping the use of this

opioid analgesic could cause a miscarriage. She also learned

about the opioid analog Suboxone, that, according to defendant,

physicians prescribed to pregnant women to help with withdrawal

symptoms. However, instead of consulting a physician to confirm

Suboxone was safe to take while pregnant and thereafter obtain a

prescription for the medication, defendant again decided to

self-medicate by obtaining the drug from a friend. She

thereafter continued to use Suboxone throughout her pregnancy

and made the conscious decision not to disclose she was taking

this medication to her obstetrician.

Defendant called Dr. Loretta P. Finnegan as an expert

witness. The Family Part admitted Dr. Finnegan as an expert in

"pediatrics and with a specialty in the area of neonatology and

specifically prenatal addiction and neonatal abstinence

syndrome." Based on a 2010 study in the New England Journal of

Medicine which "compared the effects methadone versus

Buprenorphine" (the generic term for Suboxone),4 Dr. Finnegan

testified the study found "both medications were appropriate for

pregnant women."

4 Hendrée E. Jones et al., Neonatal Abstinence Syndrome After Methadone or Buprenorphine Exposure, 363 New Eng. J. of Med. 2320 (2010).

5 A-3662-13T3 According to Dr. Finnegan, babies who are born after their

mothers have ingested Suboxone during pregnancy are closely

monitored every four hours after birth to determine the extent

of any withdrawals symptoms. Medical staff assess the severity

of the withdrawals using a twenty-one point score. The visual

symptoms include jerking, sneezing, loose stools, sucking,

hypertonia and tremors. Because defendant did not disclose she

took Suboxone to the medical staff who attended to her during

G.G.'s delivery, there was a three-day delay in the start of

treatment to alleviate the baby's withdrawal symptoms.

Dr. Finnegan testified that Suboxone is an appropriate

Free access — add to your briefcase to read the full text and ask questions with AI

New Jersey Division of Child Protection and Permanency, 133 A.3d 643, 444 N.J. Super. 325 (N.J. Ct. App. 2016).

133 A.3d 643 (New Jersey Division of Child Protection and Permanency) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related